Archive for October, 2009
A recent study determined glucocorticoid-induced osteoporosis (OP) is now treatable with Teriparatide, a synthetic form of the human parathyroid hormone. Researchers found patients with glucocorticoid-induced OP who were treated with teriparatide for 36 months had a greater increase in bone mineral density (BMD) and fewer new vertebral fractures than those treated with alendronate.
More: continued here
A Geisinger orthopaedic surgeon recently received a $97,000 grant from the Orthopaedic Trauma Association for a pilot study that will expand Geisinger’s ProvenHealth Navigator advanced medical home to include care for patients recovering from hip fractures. Wade Smith, M.D.
More: continued here
ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule. TB-402 is a novel, long acting anticoagulant that is being developed for the prevention of deep vein thrombosis (DVT) following orthopaedic surgery. The results of this study, which has recruited 315 patients, are anticipated in the second quarter of 2010.
More: continued here
Vertebrates have in common a skeleton made of segments, the vertebrae. During development of the embryo, each segment is added in a time dependent manner, from the head-end to the tail-end: the first segments to be added become the vertebrae of the neck, later segments become the vertebrae with ribs and the last ones the vertebra located in the tail (in the case of a mouse, for example).
More: continued here
Scientists questing after a long-sought new medical adhesive describe copying the natural glue secreted by a tiny sea creature called the sandcastle worm in the latest episode in the American Chemical Society’s (ACS) award-winning podcast series, “Global Challenges/Chemistry Solutions.” Such an adhesive is needed to repair bones shattered in battlefield injuries, car crashes and other accidents.
More: continued here
Springtime in Tuscany! Come to Florence to hear the world’s key opinion leaders in osteoporosis talk about the field’s ‘hot topics’ and join in clinically-oriented ‘Meet-the-Expert’ sessions, limited in size for maximum interaction between experts and participants.
More: continued here
When little Mark Blinder was diagnosed with a rare bone cancer, doctors at Lucile Packard Children’s Hospital gave his parents three agonizing options: amputate the affected arm at the shoulder, irradiate the tumor and risk a second malignancy, or try a limb-preserving surgery that had never been attempted in a toddler. Nearly a year later, Mark, now four, is thriving with a surgically implanted artificial humerus inside his cancer-free right arm.
More: continued here
Humans are exposed to aluminum from a variety of sources, including drinking water, infant formula, breast milk and some medications. Preterm infants who receive intravenous feeding solutions with aluminum, often to ensure their survival, may have reduced lumbar spine and hip bone mass in adolescence. In addition, these children also may face a potential risk of osteoporosis and hip fractures as adults.
More: continued here
The discovery of a multi-level arteriovenous malformation (AVM) in the thoracic epidural space can now bring relief to potentially thousands of suffers of chronic thoracic pain and progressive myelopothy. Identified as thoracic epidural arteriovenous malformation (T.E.A.M.), this particular AMV primarily affects younger women ages 20 to 40.
More: continued here
A new nationally representative study suggests that millions of children in the US between the ages of 1 and 11 don’t have enough vitamin D, and that non-whites, such as black and Hispanic children are especially at risk.
More: continued here





